ISSN 1662-4009 (online)

ey0015.10-17 | Psychology and quality of life | ESPEYB15

10.17 Strengths, risk factors, and resilient outcomes in adolescents with T1DM: results from diabetes MILES Youth-Australia

ME Hilliard , V Hagger , C Hendrieckx , BJ Anderson , S Trawley , MM Jack , F Pouwer , T Skinner , J Speight

To read the full abstract: Diabetes Care. 2017;40:849-855Coping strategies for people with chronic diseases include working on risk factors as well as using and employing resilience factors in daily coping strategies. Both strengthes and difficulties may be experienced by people with T1DM. In this study, strengths were strongly related to key resilient outcomes, even in the presence of well-documente...

ey0020.7-13 | Long-Term Surveillance for Endocrine Complications in Childhood Cancer Survivors | ESPEYB20

7.13. Management of childhood cancer survivors at risk for thyroid function abnormalities: A Delphi study

JJG Welch , B Ames , LE Cohen , E Gaufberg , MM Hudson , PC Nathan , L Nekhlyudov , TI Yock , W Chemaitilly , LB Kenney

Brief summary: This study used a Delphi approach to generate consensus guidelines for screening of asymptomatic childhood cancer survivors for thyroid dysfunction and recommendations for the management of abnormal thyroid screening results.A Delphi panel of 40 clinical experts (oncologists, endocrinologists, and primary care physicians) participated in three rounds of anonymous questionnaires, formatted as clinical scenarios. Consensus was defined by agr...

ey0020.13-10 | Section | ESPEYB20

13.10. Race-dependent association of high-density lipoprotein cholesterol levels with incident coronary artery disease

NA Zakai , J Minnier , MM Safford , I Koh , MR Irvin , S Fazio , M Cushman , VJ Howard , N Pamir

In Brief: In this US cohort study of 30,239 Black and White individuals aged >=45 years followed up for a median of 10 years, low baseline levels of HDL-Cholesterol (HDL-C) were associated with increased risk of coronary heart disease (CHD) in White (HR: 1.22; 95% CI: 1.05–1.43) but not in Black (HR: 0.94; 95% CI: 0.78–1.14) adults (P-interaction by race =0.08).Comment: The established clinical risk factors for coronary heart disea...

ey0019.3-10 | New genes | ESPEYB19

3.10. GWAS of thyroid dysgenesis identifies a risk locus at 2q33.3 linked to regulation of Wnt signaling

S Narumi , R Opitz , K Nagasaki , K Muroya , Y Asakura , M Adachi , K Abe , C Sugisawa , P Kuhnen , T Ishii , MM Nothen , H Krude , T Hasegawa

Hum Mol Genet. 2022 May 10:ddac093. doi: 10.1093/hmg/ddac093. Online ahead of print. PMID: 35535691Brief Summary: This genome-wide association study (GWAS) of patients with thyroid dysgenesis identified a genetic risk locus for thyroid athyreosis and ectopy. In depth genetic analyses of the disease associated region suggested a new disease mechanism of thyroid dysgenesis mediated by impaired Wnt ...

ey0019.9-4 | Metabolic risk in childhood cancer | ESPEYB19

9.4. Metabolic syndrome in male survivors of pediatric allogeneic hematopoietic stem cell transplantation: impact of total body irradiation, low-grade inflammation, and hypogonadism

E Muhic , S Mathiesen , MM Nielsen , A Suominen , K Sorensen , M Ifversen , RL Nolsoe , KM Pedersen , P Lahteenmaki , BG Nordestgaard , A Juul , K Jahnukainen , K Muller

klaus.mueller@regionh.dk Transplant Cell Ther. 2021 Sep;27(9): 778.e1-778.e8. PMID: 34091072.Brief Summary: Several studies in cancer survivors have reported an increased prevalence of metabolic syndrome (MetS), which is often observed in the absence of overt obesity. Data about MetS in survivors of pediatric hematopoietic stem cell transplantation (HSCT) are scarce. This cross-sectional cohort study...

ey0019.10-17 | New treatments | ESPEYB19

10.17. Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and preclinical models of insulin-deficient diabetes

T Fuselier , de Sa P Mota , MMF Qadir , B Xu , C Allard , MM Meyers , JP Tiano , BS Yang , V Gelfanov , SH Lindsey , RD Dimarchi , F Mauvais-Jarvis

Cell Rep Med 2022;3:100598. https://pubmed.ncbi.nlm.nih.gov/35492248/Brief Summary: This study used a combination of mice models and cultured human islets to show that a glucagon-like peptide-1 (GLP-1) and estrogen (E2) dual agonist (GLP1-E2) provides superior protection from insulin-deficient diabetes compared to GLP-1 and E2 monoagonists. Pancreatic islet protection...

ey0016.8-10 | Clinical Trials - New Treatments | ESPEYB16

8.10. Treatment of Primary Aldosteronism with mTORC1 Inhibitors

B Trinh , M Hepprich , MJ Betz , T Burkard , C Cavelti-Weder , E Seelig , F Meienberg , DV Kratschmar , F Beuschlein , M Reincke , A Odermatt , MN Hall , MY Donath , MM Swierczynska

To read the full abstract: J Clin Endocrinol Metab. 2019; pii: jc.2019–00563.Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, affecting ~6% of the adult general hypertensive population. Patients with PA are at increased risk of cerebrovascular and cardiovascular morbidity, renal abnormalities and metabolic syndrome. The activity of mTORC1 ...

ey0020.9-9 | Genetic Obesity and Genetic Risk Score | ESPEYB20

9.9. Genetic risk score enhances the risk prediction of severe obesity in adult survivors of childhood cancer

Y Sapkota , W Qiu , SB Dixon , CL Wilson , Z Wang , J Zhang , W Leisenring , EJ Chow , S Bhatia , GT Armstrong , LL Robison , MM Hudson , A Delaney , Y Yasui

Brief summary: This study evaluated the ability of genetic risk scores to predict severe obesity in adult survivors of childhood cancer. Data from 2548 survivors of European ancestry from the St. Jude Lifetime Cohort Study was analyzed and findings were validated in 6064 survivors from the Childhood Cancer Survivor Study. Survivors with higher genetic risk scores had significantly higher odds of severe obesity. Adding genetic risk scores to prediction models that included canc...

ey0020.10-7 | New Drugs for Children with T2DM | ESPEYB20

10.7. Maternal diabetes in youth-onset type 2 diabetes is associated with progressive dysglycemia and risk of complications

RD Shah , SD Chernausek , L El Ghormli , ME Geffner , J Keady , MM Kelsey , R Farrell , B Tesfaldet , JB Tryggestad , M Van Name , E Isganaitis

Brief summary: This analysis of data from the TODAY study examined the impact of parental diabetes on outcomes in young individuals with T2D during over 12 years of follow-up. This novel observation demonstrates that parental diabetes affects not only earlier T2D onset, but also more rapid long-term progression and more complications.Comment: This study showed that T2D diagnosis in either parent was associated with younger age at T2D diagnosis in their c...

ey0021.12-8 | Pregnancy and Youth Onset T2D | ESPEYB21

12.8. Impact of youth onset type 2 diabetes during pregnancy on microvascular and cardiac outcomes

JB Tryggestad , KL Drews , L Mele , S Arslanian , SD Chernausek , EN Escaname , M Geffner , E Isganaitis , J Sprague , MM; TODAY Study Group. Kelsey

Brief Summary: This observational study showed that pregnancy increases the risk of hyperfiltration in women with youth-onset T2D, but not other micro or macrovascular complications.Comment: This study examined whether pregnancy exacerbates health outcomes in young women with T2D, particularly by testing for changes in the occurrence of microvascular and macrovascular complications. Previous findings showed that women in their fourth decade experience a ...